Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients (Q30308738)

16 June 2017

1 reference

title

Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients (English)

1 reference

16 June 2017

R Santen

1

1 reference

16 June 2017

M H Jeng

2

1 reference

16 June 2017

J P Wang

3

1 reference

16 June 2017

R Song

4

1 reference

16 June 2017

S Masamura

5

1 reference

16 June 2017

R McPherson

6

1 reference

16 June 2017

S Santner

7

1 reference

16 June 2017

W Yue

8

1 reference

16 June 2017

W S Shim

9

1 reference

16 June 2017

1 December 2001

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

16 June 2017

1 reference

16 June 2017

79

1 reference

16 June 2017

1-5

1 reference

16 June 2017

115-125

1 reference

16 June 2017

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Endocrine treatment of breast cancer in women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Identification of a negative regulatory function for steroid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

A wide range of sensitivities to androgens develops in cloned Shionogi mouse mammary tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Low Androgen Levels Induce the Development of Androgen-Hypersensitive Cell Clones in Shionogi Mouse Mammary Carcinoma Cells in Culture

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Changing Sensitivity of the Pubertal Gonadal Hypothalamic Feedback Mechanism in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Perturbations of negative feedback sensitivity in agonadal patients undergoing estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

The Endocrine Control of Seasonal Reproductive Function in the Ewe: A Marked Change in Response to the Negative Feedback Action of Estradiol on Luteinizing Hormone Secretion12

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Prolonged Negative Feedback Suppression after Estradiol Administration: Proposed Mechanism of Eugonadal Secondary Amenorrhea*

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Modulation of TAT gene induction by glucocorticoids involves a neutralizing sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Letrozole, a new oral aromatase inhibitor: randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer. Letrozole International Trial Group (AR/BC3).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Use of aromatase inhibitors in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Differential Regulation of Gene Expression by Estrogen in Estrogen Growth-Independent and -Dependent MCF-7 Human Breast Cancer Cell Sublines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

The control of hormone-dependent breast cancer growth--are we talking about estrogen alone?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

The involvement of the MAPK signalling pathway in the adaptation of MCF-7 cells to long-term oestrogen deprivation.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Enhanced androgen sensitivity in serum-free medium of a subline of the LNCaP human prostate cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Clinical review 37: Endocrine treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900151-0

7 January 2021

10.1016/S0960-0760(01)00151-0

Identifiers

DOI

1 reference

16 June 2017

1 reference